Vaccine development: from concept to clinic
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Cambridge
Royal Society of Chemistry
[2023]
|
| Schriftenreihe: | Drug development and pharmaceutical science
No. 3 |
| Schlagworte: | |
| Online-Zugang: | DE-19 Volltext |
| Beschreibung: | Auf der Webseite ist, abweichend vom PDF, 2022 als Erscheinungsjahr angegeben |
| Beschreibung: | 1 Online-Ressource (xvii, 303 Seiten) |
| ISBN: | 9781839162572 9781839162589 |
| DOI: | 10.1039/9781839162572 |
Internformat
MARC
| LEADER | 00000nmm a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV048670992 | ||
| 003 | DE-604 | ||
| 005 | 20240617 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 230123s2023 |||| o||u| ||||||eng d | ||
| 020 | |a 9781839162572 |c PDF |9 978-1-83916-257-2 | ||
| 020 | |a 9781839162589 |c epub |9 978-1-83916-258-9 | ||
| 024 | 7 | |a 10.1039/9781839162572 |2 doi | |
| 035 | |a (OCoLC)1369559374 | ||
| 035 | |a (DE-599)KXP1821530438 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-11 | ||
| 082 | 0 | |a 615.372 | |
| 084 | |a 58.28 |2 bkl | ||
| 245 | 1 | 0 | |a Vaccine development |b from concept to clinic |c edited by A. Krishna Prasad, Citranvi Biosciences, Chapel Hill, NC, USA |
| 264 | 1 | |a Cambridge |b Royal Society of Chemistry |c [2023] | |
| 264 | 4 | |c © 2023 | |
| 300 | |a 1 Online-Ressource (xvii, 303 Seiten) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 1 | |a Drug development and pharmaceutical science |v No. 3 | |
| 500 | |a Auf der Webseite ist, abweichend vom PDF, 2022 als Erscheinungsjahr angegeben | ||
| 650 | 0 | 7 | |a Pharmazeutische Technologie |0 (DE-588)4045699-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Impfstoff |0 (DE-588)4026655-2 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Impfstoff |0 (DE-588)4026655-2 |D s |
| 689 | 0 | 1 | |a Pharmazeutische Technologie |0 (DE-588)4045699-7 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Prasad, A. Krishna |0 (DE-588)1279561734 |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-1-78801-877-7 |
| 830 | 0 | |a Drug development and pharmaceutical science |v No. 3 |w (DE-604)BV048800494 |9 3 | |
| 856 | 4 | 0 | |u https://doi.org/10.1039/9781839162572 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-1-RSEK |a ZDB-11-EBC | ||
| 966 | e | |u https://doi.org/10.1039/9781839162572 |l DE-19 |p ZDB-1-RSEK |q UBM_Paketkauf_2022 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1805077530417299456 |
|---|---|
| adam_text | |
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author2 | Prasad, A. Krishna |
| author2_role | edt |
| author2_variant | a k p ak akp |
| author_GND | (DE-588)1279561734 |
| author_facet | Prasad, A. Krishna |
| building | Verbundindex |
| bvnumber | BV048670992 |
| collection | ZDB-1-RSEK ZDB-11-EBC |
| ctrlnum | (OCoLC)1369559374 (DE-599)KXP1821530438 |
| dewey-full | 615.372 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.372 |
| dewey-search | 615.372 |
| dewey-sort | 3615.372 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| discipline_str_mv | Medizin |
| doi_str_mv | 10.1039/9781839162572 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nmm a2200000 cb4500</leader><controlfield tag="001">BV048670992</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20240617</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">230123s2023 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781839162572</subfield><subfield code="c">PDF</subfield><subfield code="9">978-1-83916-257-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781839162589</subfield><subfield code="c">epub</subfield><subfield code="9">978-1-83916-258-9</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1039/9781839162572</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1369559374</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)KXP1821530438</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-11</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.372</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">58.28</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Vaccine development</subfield><subfield code="b">from concept to clinic</subfield><subfield code="c">edited by A. Krishna Prasad, Citranvi Biosciences, Chapel Hill, NC, USA</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge</subfield><subfield code="b">Royal Society of Chemistry</subfield><subfield code="c">[2023]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2023</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xvii, 303 Seiten)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Drug development and pharmaceutical science</subfield><subfield code="v">No. 3</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Auf der Webseite ist, abweichend vom PDF, 2022 als Erscheinungsjahr angegeben</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Technologie</subfield><subfield code="0">(DE-588)4045699-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmazeutische Technologie</subfield><subfield code="0">(DE-588)4045699-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Prasad, A. Krishna</subfield><subfield code="0">(DE-588)1279561734</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-1-78801-877-7</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Drug development and pharmaceutical science</subfield><subfield code="v">No. 3</subfield><subfield code="w">(DE-604)BV048800494</subfield><subfield code="9">3</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1039/9781839162572</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-RSEK</subfield><subfield code="a">ZDB-11-EBC</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1039/9781839162572</subfield><subfield code="l">DE-19</subfield><subfield code="p">ZDB-1-RSEK</subfield><subfield code="q">UBM_Paketkauf_2022</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV048670992 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T21:22:48Z |
| indexdate | 2024-07-20T06:14:39Z |
| institution | BVB |
| isbn | 9781839162572 9781839162589 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034045562 |
| oclc_num | 1369559374 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-11 |
| owner_facet | DE-19 DE-BY-UBM DE-11 |
| physical | 1 Online-Ressource (xvii, 303 Seiten) |
| psigel | ZDB-1-RSEK ZDB-11-EBC ZDB-1-RSEK UBM_Paketkauf_2022 |
| publishDate | 2023 |
| publishDateSearch | 2023 |
| publishDateSort | 2023 |
| publisher | Royal Society of Chemistry |
| record_format | marc |
| series | Drug development and pharmaceutical science |
| series2 | Drug development and pharmaceutical science |
| spelling | Vaccine development from concept to clinic edited by A. Krishna Prasad, Citranvi Biosciences, Chapel Hill, NC, USA Cambridge Royal Society of Chemistry [2023] © 2023 1 Online-Ressource (xvii, 303 Seiten) txt rdacontent c rdamedia cr rdacarrier Drug development and pharmaceutical science No. 3 Auf der Webseite ist, abweichend vom PDF, 2022 als Erscheinungsjahr angegeben Pharmazeutische Technologie (DE-588)4045699-7 gnd rswk-swf Impfstoff (DE-588)4026655-2 gnd rswk-swf Impfstoff (DE-588)4026655-2 s Pharmazeutische Technologie (DE-588)4045699-7 s DE-604 Prasad, A. Krishna (DE-588)1279561734 edt Erscheint auch als Druck-Ausgabe 978-1-78801-877-7 Drug development and pharmaceutical science No. 3 (DE-604)BV048800494 3 https://doi.org/10.1039/9781839162572 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Vaccine development from concept to clinic Pharmazeutische Technologie (DE-588)4045699-7 gnd Impfstoff (DE-588)4026655-2 gnd Drug development and pharmaceutical science |
| subject_GND | (DE-588)4045699-7 (DE-588)4026655-2 |
| title | Vaccine development from concept to clinic |
| title_auth | Vaccine development from concept to clinic |
| title_exact_search | Vaccine development from concept to clinic |
| title_exact_search_txtP | Vaccine development from concept to clinic |
| title_full | Vaccine development from concept to clinic edited by A. Krishna Prasad, Citranvi Biosciences, Chapel Hill, NC, USA |
| title_fullStr | Vaccine development from concept to clinic edited by A. Krishna Prasad, Citranvi Biosciences, Chapel Hill, NC, USA |
| title_full_unstemmed | Vaccine development from concept to clinic edited by A. Krishna Prasad, Citranvi Biosciences, Chapel Hill, NC, USA |
| title_short | Vaccine development |
| title_sort | vaccine development from concept to clinic |
| title_sub | from concept to clinic |
| topic | Pharmazeutische Technologie (DE-588)4045699-7 gnd Impfstoff (DE-588)4026655-2 gnd |
| topic_facet | Pharmazeutische Technologie Impfstoff |
| url | https://doi.org/10.1039/9781839162572 |
| volume_link | (DE-604)BV048800494 |
| work_keys_str_mv | AT prasadakrishna vaccinedevelopmentfromconcepttoclinic |